Carlsmed, Inc.
CARL
$14.50
$0.050.35%
NASDAQ
| 03/31/2025 | |||||
|---|---|---|---|---|---|
| Revenue | 100.33% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 100.33% | ||||
| Cost of Revenue | 79.54% | ||||
| Gross Profit | 108.41% | ||||
| SG&A Expenses | 77.88% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 52.74% | ||||
| Operating Income | -7.32% | ||||
| Income Before Tax | -5.18% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -5.18% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -5.18% | ||||
| EBIT | -7.32% | ||||
| EBITDA | -7.37% | ||||
| EPS Basic | -7.74% | ||||
| Normalized Basic EPS | 2.29% | ||||
| EPS Diluted | -7.74% | ||||
| Normalized Diluted EPS | 2.29% | ||||
| Average Basic Shares Outstanding | 7.58% | ||||
| Average Diluted Shares Outstanding | 7.58% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||